Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Deloitte
QuintilesIMS
Mallinckrodt
Healthtrust
Chinese Patent Office
Johnson and Johnson
Colorcon
McKinsey

Generated: December 12, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Bivalirudin

« Back to Dashboard

Bulk Pharmaceutical API Sources for Bivalirudin

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ➤ Sign Up 16129704 ➤ Sign Up
ChemMol ➤ Sign Up 2100022 ➤ Sign Up
ChemMol ➤ Sign Up 44013729 ➤ Sign Up
ChemMol ➤ Sign Up 49401995 ➤ Sign Up
AKos Consulting & Solutions ➤ Sign Up AKOS015994644 ➤ Sign Up
Chembase.cn ➤ Sign Up 2092 ➤ Sign Up
AK Scientific, Inc. (AKSCI) ➤ Sign Up S115 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Argus Health
Deloitte
US Army
Express Scripts
Queensland Health
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.